アステラス製薬株式会社 · ASTELLAS PHARMA INC.
Last · —$2262.500.00 (0.00%)live · yahoo · 2m ago
Market cap——
P/E · TTM11.3fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | ¥2.14T |
|---|---|
| Operating income | ¥382.6B |
| Net income | ¥291.5B |
| Free cash flow | ¥510.9B |
| Operating margin | 17.9% |
| Net margin | 13.6% |
| Return on equity | 15.9% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2024-06-20
- Current Ratio Low
Red flags
- Current Ratio Low — Current ratio 0.93
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
$60.22
Est. revenue
594.1B
Documents
FormReporting forFiledFlags